Trade Madrigal Pharmaceuticals, Inc. - MDGL CFD
Add to favourite- Summary
- Historical Data
| Spread | 1.15 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 217.22 |
| Open | 210.89 |
| 1-Year Change | -30.96% |
| Day's Range | 204.31 - 210.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| May 6, 2024 | 235.44 | 4.59 | 1.99% | 230.85 | 236.18 | 227.86 |
| May 3, 2024 | 229.15 | 9.28 | 4.22% | 219.87 | 234.01 | 219.86 |
| May 2, 2024 | 215.71 | 4.85 | 2.30% | 210.86 | 217.90 | 206.98 |
| May 1, 2024 | 209.94 | 7.62 | 3.77% | 202.32 | 217.46 | 200.32 |
| Apr 30, 2024 | 203.89 | 3.36 | 1.68% | 200.53 | 209.02 | 199.27 |
| Apr 29, 2024 | 200.68 | 7.30 | 3.77% | 193.38 | 201.79 | 191.13 |
| Apr 26, 2024 | 193.21 | 1.75 | 0.91% | 191.46 | 194.84 | 188.88 |
| Apr 25, 2024 | 194.23 | -6.14 | -3.06% | 200.37 | 200.87 | 190.08 |
| Apr 24, 2024 | 204.17 | -12.38 | -5.72% | 216.55 | 219.15 | 204.03 |
| Apr 23, 2024 | 217.99 | 6.63 | 3.14% | 211.36 | 225.36 | 208.29 |
| Apr 22, 2024 | 213.37 | 7.49 | 3.64% | 205.88 | 216.45 | 197.15 |
| Apr 19, 2024 | 211.87 | -8.49 | -3.85% | 220.36 | 224.25 | 205.87 |
| Apr 18, 2024 | 222.12 | -2.40 | -1.07% | 224.52 | 226.92 | 220.45 |
| Apr 17, 2024 | 228.32 | -4.93 | -2.11% | 233.25 | 233.73 | 223.86 |
| Apr 16, 2024 | 232.82 | 5.46 | 2.40% | 227.36 | 235.71 | 221.97 |
| Apr 15, 2024 | 230.90 | -5.95 | -2.51% | 236.85 | 242.42 | 228.62 |
| Apr 12, 2024 | 236.37 | -5.93 | -2.45% | 242.30 | 243.58 | 236.08 |
| Apr 11, 2024 | 244.85 | 0.00 | 0.00% | 244.85 | 248.32 | 242.31 |
| Apr 10, 2024 | 244.00 | 3.14 | 1.30% | 240.86 | 245.70 | 240.75 |
| Apr 9, 2024 | 248.61 | -1.23 | -0.49% | 249.84 | 252.99 | 243.64 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Madrigal Pharmaceuticals, Inc. Company profile
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 20% to $241.8M. Higher net loss reflects R & D increase of 11% to $194.5M (expense), G & A increase from $10M to $21.1M (expense), Stock-based Compensation in SGA increase of 36% to $16.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$13.09 to -$14.63.
Equity composition
Common Stock $.0001 Par, 10/10, 100M auth., 42,166,779 issd. Insiders control approx. 37.8%. IPO: 2/06/07, 5M shares @ $10 per share by Bear, Stearns & Co. Inc.
| Industry: | Bio Therapeutic Drugs |
200 Barr Harbor Dr Ste 400
WEST CONSHOHOCKEN
PENNSYLVANIA 19428-2978
US
News
Bank of England preview: possible rate cut in summer?
The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.
12:39, 8 May 2024
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com